# I. Background lthough, the global maternal deaths dropped from 532,000 in the 1990s to 303,000 in 2015 (1), the burden has remained unacceptably high. Furthermore, estimates show that 99% of all maternal deaths occur in low-and middle-income countries with 66% of maternal deaths occurring in sub-Saharan Africa (1). Improvement of maternal health indicators calls for health system strengthening. One of the six important health system pillars is ensuring availability of medicine and supplies. For maternal health, lack or challenge in such important pillar is behind a number of preventable maternal deaths globally, and Tanzania is not an exception. Availability and provision of essential medicines including parenteral antibiotics, uterotonic drugs, parenteral anticonvulsants and anaesthetic drugs; and equipment including manual vacuum aspirators, vacuum extractor and set for basic neonatal resuscitation are therefore vital in addressing the direct causes of maternal and newborn deaths. Major direct causes of maternal deaths including infections, hypertensive disease in pregnancy and eclampsia, bleeding, obstructed labor, abortion complications (2,3) and causes of newborn deaths can be averted by providing Emergency Obstetric and Neonatal care (EmONC) (4). Tanzania (comprised of mainland and Zanzibar islands) like other sub-Saharan Africa has a high maternal mortality ratio of 556 deaths per 100,000 live births (5) with a significant variation between regions and geographical areas. Zanzibar records maternal mortality ratio as high as 350/100,000 live births (6). While Zanzibar has made significant gains in reducing infant mortality from 54 deaths per 1000 live births in 2010 to 45 deaths per 1000 live births in 2015. Facilitybased data show an increase of maternal deaths from 187 per 100,000 live births in 2014 to 276 maternal deaths per 100,000 live births in 2016. For the neonatal mortality, another important indicator, is still very high at a level of 25 neonatal deaths per 1000 live births (5). While poor access to health facilities contribute to high burdens of maternal and neonatal mortality in many parts of the world (7), women in Zanzibar may have a different set of challenges as 95% of the population live close proximity to health facilities and have access to care (2). Evidence gathered from Zanzibar revealed shortage of drugs and supplies contribute to this poor trend in maternal mortality. The ministry of health and implementing UNFPA commissioned a survey in 2012 to assess Emergency Obstetric and Neonatal Care (EmONC) indicators in the isles that show similar challenges reported. However, how much has been done with respect to providing the facilities with equipment and medical supplies since those studies were conducted remains unknown. This is a follow up survey aimed to examine the changes made in this regard. It aimed at documenting the situation at glance with respect to essential medicines and equipment for provision of quality EmONC in Zanzibar. # II. # Methods # a) Study design A cross sectional mixed methods study design employing both quantitative and qualitative approaches was used. The quantitative approach used systematic observation while the qualitative approach adopted indepth interviews with key stakeholders on availability of medicine for provision of maternal and newborn care. # b) Study setting c) Data collection Data collection was done using the Averting Maternal Death and Disability (AMDD) (9) program tools to observe the availability of medicines and equipment and medical supplies for EmONC. The tools were formatted to suit Open Data Kit (ODK) format and uploaded to tablets that were used for data collection. For the qualitative part, a semi-structured interview guide was used to interview the in-charge or a health worker who provides maternal and new born services in the respective health facility. The later was developed based on prior knowledge of the investigators and literature existed on the question under study. The interviews were scheduled to fit the convenience of the informant and they were carried out in privacy within the facility. Experienced qualitative researchers who were accompanied by trained research assistants for notes taking and audio recording carried out the interviews in Swahili, using digital voice recorders. # d) Data analysis Quantitative data were transformed from the ODK server to STATA for analysis. Descriptive analyses were conducted and results summarized in frequency tables and figures. The health facilities were grouped hospitals and maternity hospital, PHCC and PHCU+/PHCU. For the qualitative data analysis, first, we transcribed verbatim all audio-recorded interviews. In order to become familiar with the content and context, all authors read the full transcripts and field notes repeatedly before the start of analysis. We used a hybrid thematic data analysis approach; this approach used both inductive and deductive reasoning. # Results # a) Availability of essential drugs Levels of availability of essential medicine varied widely (Table 1). The most common available antibiotic was amoxicillin, available in 86.3% of all health facilities. The least available were cephazoline sodium, chloramphenicol (injection), clindamycin, and cloxacillin sodium all in 3.9% of all health facilities respectively. In almost all essential medicines, availability is lower in lower levels health facilities compared to PHCC and above levels. For anticonvulsants, magnesium sulphate was available in only 76.5% of facilities providing delivery services. Only two thirds of facilities had diazepam while The study was approved by the Zanzibar Medical Research Ethics Council (ZAMREC) and the permission to conduct the study was given by the Ministry of Health of the Revolutionary Government and respective regions, districts and facility authorities. Participation into the study was voluntary, and researchers ensured confidentiality and privacy of participants. Participants signed an informed consent before interviews and were free to stop the interview at any time without repercussion. This study was part of the larger study to assess EmONC in Zanzibar in the year 2018. The health care system is organized into three levels, the primary, secondary, and tertiary levels. More details on the study setting and sampling are provided elsewhere (8). The focus of this study is on the 51 facilities offering delivery services including the National, Mnazi Mmoja hospital; five district hospitals and one maternity hospital; four primary health care centers (PHCC); 33 primary health care unit plus (PHCU+) and seven primary health care units (PHCU). into 4, hospitals including the National hospital, district phenobabrbitone was available in only one quarter. In this regard too, availability levels were lower in lower levels health facilities compared to those in PHCC and above. For antihypertensives, Nifedipine was available in three quarter of the health facilities. However, other essential antihypertensive medicines such as methyl-dopa and hydralazine were available in only 27.5% and 21.6% respectively. Oxytocin was available in 92.2% of the facilities, however one fourth of facilities did not have misoprostol and ergometrine was rarely available. The trend was almost the same for all levels of facilities. # b) Stock out of drugs within the past three and six months To get the insight of the real situation we also collected data on the drugs stock out within the past three and six months. The essential antibiotics assessed included ampicillin, gentamicin injection, metronidazole injection, penicillin G, and procaine benzylpenicillin. Table 2 shows that, a total of 34 health facilities confirmed they had stock out of any of the mentioned essential antibiotic. This is 67% of all facilities and the challenge is higher in lower level facilities compared to higher ones. More than two thirds of PHCU had such stock out. In terms of duration, the analyses suggest that 12% of facilities had shortage in the past three months and all of them in lower level facilities. Compared to antibiotics, there was no significant challenge in stock out of oxytocics. Only three out of 51 facilities reported stock out of oxytocics. All of them are the low-level health facilities. Looking into three-or six-months records, only one facility had such shortage. From the interviews, majority of the participants (public and private facilities) reported that the frequency of drugs stock out has declined as compared to previous years. # "About drugs we thank God because the most used drugs here like hydralazine, methyldopa, and antibiotics are available most of the time (General Nurse-1). In other facilities despite acknowledging the declining in stock out frequency in general, participants stated that there was still frequently stock outs for some specific drugs. # "Most of the drugs we mainly use in maternity are available, but for the last two months (March and April) we have been getting inadequate ferrous sulphate drugs" (General nurse-2). c) Availability of equipment Majority of the delivery health facilities had items included in the delivery set. The least found items in the delivery set were long gloves, and pean artery forceps which were found in only 13.7% and 37.3% of all the facilities. The shortage of equipment affected lower level facilities more than higher level facilities (Table 3). Table 4 shows the results of availability of manual vacuum aspiration equipment in health facility providing delivery services. Of all the facilities, less than half had the equipment. It is worth-noting that, lower level health facilities bears the bigger brunt of such deficiency. From the interviews with health workers, they confirmed the shortage of equipment and added that some of the available equipment were worn out or outdated. The outdated equipment were mostly available in public health facilities. "We are in a modernized world but surprisingly we are still using the old pumping BP machine that uses not less than 10 minutes to attend one patient instead of using monitor that takes one minute to measure BP, PR, Temperature, oxygen saturation. We need monitor so as to reduce waiting time for clients/patients when checking for vital signs". (labor ward nurse-1) To explain the magnitude of the situation, in some facilities the main reported challenge was on neonatal resuscitation. The participants stated that on absence of resuscitation table it becomes very hard to ensure quality of care to the newborn. "Newborn services we provide, I can say it is of quality. But there is what we call resuscitation table which we don't have it in labour ward as well as oxygen cylinder. So when we get a baby with difficulty breathing we are not in a position to help him/her breath instead we refer the baby" (Nurse-Midwife-3). # IV. Discussion Essential medicine and supplies is one of the six important health system building blocks as proposed by the WHO (11). Lack or challenges in meeting the demand of essential medicine and supplies have negative consequences in addressing any health challenge (12), maternal and new born health is no exception. Efforts to improve maternal health in the country has been receiving unequal gains. Lack or poor access and availability of essential medicine and supplies remain among the challenges in delivering quality emergency maternal and newborn care (EmONC) (13,14). In realizing its needs, the revolutionary government of Zanzibar in collaboration with UNFPA conducted a baseline survey to examine key aspects and needs to deliver EmONC in 2012. One of the objectives was to examine availability of essential medicine for meeting EmONC targets in the isles. The evidence generated helped to guide the selected interventions and investment thereof. In looking on the remaining challenges, we conducted the current study to examine the current situation in terms of essential medicine and medical supplies. In terms of essential medicine to prevent maternal and new-born deaths, evidence collected reveleal a persistent challenge in accessing some of the essential medicine. For maternal and newborn challenges, the leading causes of deaths include infections such as postpartum sepsis, haemorrhage both before, during, and after delivery, pregnancy induced hypertension and eclampsia, among others. Addressing such challenges call for ensuring availability of preventive and curative medicines at all the times in all facilities where delivery takes place. For antibiotics, the commonest found essential item was amoxicillin while all others were at the level below 50%. The challenge in availability is more common in lower level facilities compared to higher ones. This was the same for all other medicine. The challenge of poor availability of essential medicine in low level health facilities is common in other settings. Delivery of quality health services especially that of EmONC depends very much in availability of quality essential medicine (15). This can be improved when needs are established in time and medicines are ordered and delivered in time (16). Apart from infections, other causes of maternal mortality include haemorrhage and pregnancy induced hypertension (16). This is also common trend in Tanzania (17). It is therefore essential to ensure availability of essential medicine to address these two conditions (18). To ensure quality EmONC service delivery, availability of antihypertensive and oxytocics is of paramount importance (15). In this survey, essential anti-colvusants were available in only two thirds of the facilities offering delivery services. Hypertensives were also not available in majority of health facilities. This is worrisome and could be one of the factors behind lives lost in health facilities in Zanzibar. Oxytocics are widely available and this is a significant improvement compared to the previous rates. Although some essential medicines are somehow not available in some surveyed facilities, interviewed health workers explained that the situation has improved significantly compared to the past. Zanzibar has made significant improvement in ensuring availability essential medical supplies to address EmONC. Our observation and testimonies from the interviewed health workers revealed such improvement in supplies making up the delivery kit, resuscitation equipment, but not manual vacuum aspiration equipment. Such improvement needs to be sustained and extending to ensure replacement of wornout equipment to ensure delivery of quality health services (19). V. # Study Limitation Some of the data used a cross sectional design that may limit studying causality. However, we employed mixed method design to ameliorate effects posed by designs. For example, the use of qualitative design helped to understand opinions from health workers and therefore somehow explain some of the results we presented. Despite covering all districts and regions in Zanzibar, data on EmONC presented in this report can lack generalizability to beyond health facilities. The use of qualitative survey which was not in the previous survey has captured voices of health workers in challenges they face in EmONC services as well as training and skills needed. Moreover, we used electronic data collection system that reduces chances of errors in data collection and cleaning. Quality of this data is therefore improved compared to the previous survey. # VI. Conclusion and Recommendations Availability of essential medicine and supplies for EmONC have improved in Zanzibar, but remains a challenge particularly in low level of health facilities. Efforts are needed to ensure of medicine and supplies to carter for all emergencies including anticonvulsants, antibiotics, and antihypertensives. Health facilities lack equipment for neonatal resuscitation. # Abbreviations 1DrugsHealth facility levelTotalHospitalsPHCCPHCU+/PHCUN =51N = 7N = 4N = 40n (%)n (%)n (%)n (%)AntibioticsAmoxicillin44 (86.3)7 (100.0)4 (100.0)33 (82.5)Ampicillin10 (19.6)2 (28.6)1 (2.0)7 (17.5)Cephazoline sodium2 (3.9)0 (0.0)0 (0.0)2 (5.0)Cefixime6 (11.8)3 (42.9)1 (25.0)2 (5.0)Ceftriaxone34 (6.7)6 (85.7)4 (100.0)24 (60.0)Chloramphenicol (injection)2 (3.9)1 (14.3)0 (0.0)1 (2.5)Clindamycin2 (3.9)1 (14.3)0 (0.0)1 (2.5)Cloxacillin sodium2 (3.9)0 (0.0)0 (0.0)2 (5.0)Gentamycin15 (29.4)7 (100.0)1 (25.0)7 (17.5)Metronidazole injection20 (39.2)7 (100.0)4 (100.0)9 (22.5)Benzyl penicillin17 (33.3)5 (71.4)2 (50.0)10 (25.0)Procaine Benzylpenicillin19 (37.3)5 (71.4)1 (25.0)13 (32.5)AnticonvulsantsMagnesium sulphate (injection)39 (76.5)7 (100.0)4 (100.0)28 (70.0)Diazepam31 (60.8)6 (85.7)3 (75.0)22 (55.0)Phenobarbitone11 (21.6)3 (42.9)1 (25.0)7 (17.5)Phenyton4 (7.8)2 (28.6)0 (0.0)2 (5.0)AntihypertensivesHydralazine11 (21.6)7 (100.0)2 (50.0)2 (5.0)Labetalol1 (2.0)1 (14.3)0 (0.0)0 (0.0)Methyldopa14 (27.5)7 (100.0)1 (25.0)6 (15.0)Nifedipine39 (76.5)6 (85.7)4 (100.0)29 (72.5)OxytocicsOxytocin47 (92.2)7 (100.0)4 (100.0)36 (90.0)Ergometrine2 (3.9)1 (14.3)0 (0.0)1 (2.5)Misoprostol35 (68.6)7 (100.0)4 (100.0)24 (60.0) 2Drugs 3Equipment and suppliesHealth facility levelTotalHospitalsPHCCPHCU+/PHCU(N=51)(N=7)(N=4)(N=40)n (%)n (%)n (%)n (%)Artery forceps, 18cm, CVD33 (64.7)3 (42.9)3 (75.0)27 (67.5)Sponge (ring) forceps36 (70.6)7 (100.0)3 (75.0)26 (65.0)Dissecting forceps, standard pattern32 (67.4)5 (71.4)3 (75.0)24 (60.0)Pean artery forceps, straight19 (37.3)4 (57.1)1 (25.0)14 (35.0)Cord-cutting scissors, curved,41 (80.4)6 (85.7)3 (75.0)32 (80.0)Cord ties36 (70.6)5 (71.4)2 (50.0)29 (72.5)Episiotomy scissors, angular31 (60.8)5 (71.4)3 (75.0)23 (57.5)Straight stitch scissors23 (45.1)4 (57.1)3 (75.0)16 (40.0)Gloves45 (88.2)7 (100.0)4 (100.0)34 (85.0)Long gloves7 (13.7)4 (57.1)0 (0.0)3 (7.5)Plastic sheeting30 (58.8)5 (71.4)3 (75.0)22 (55.0)Gauze swabs47 (92.2)7 (100.0)4 (100.0)36 (90.0)Clothes14 (27.5)4 (57.1)2 (50.0)8 (20.0) 4Equipment and suppliesHealth facility levelTotalHospitalsPHCCPHCU+/PHCU(N=51)(N=7)(N=4)(N=40)n (%)n (%)n (%)n (%)Vacuum aspirators/syringes22 (43.1)4 (57.1)4 (100.0)14 (35.0)Silicone lubricant9 (17.7)2 (28.6)1 (25.0)6 (15.0)Other lubricant oil6 (11.8)2 (28.6)3 (75.0)1 (2.5)Flexible cannulae (all sizes)13 (25.5)3 (42.9)2 (50.0)8 (20.0) 5 5Equipment and suppliesHealth facility levelTotalHospitalsPHCCPHCU+/PHCU(N=51)(N=7)(N=4)(N=40)n (%)n (%)n (%)n (%)Mucus extractor27 (52.9)3 (42.9)3 (75.0)21 (52.5)Infant face masks, sizes 0,1,241 (80.4)7 (100.0)4 (100.0)30 (75.0)Ambu (ventilator) bag46 (90.2)7 (100.0)4 (100.0)35 (87.5)Suction 12 Ch28 (54.9)6 (85.7)4 (100.0)18 (45.0)Infant laryngoscope with spare bulb and batteries5 (9.8)2 (28.6)1 (25.0)2 (5.0)Endotracheal tubes, 3.5, 3.05 (9.8)2 (28.6)1 (25.0)2 (5.0)Disposable uncuffed tracheal tubes, sizes 2.0 to 3.54 (7.8)1 (14.3)0 (0.0)3 (7.5)Suction aspirator (operated by foot or electrically)20 (39.2)5 (71.4)2 (50.0)13 (32.5)Mucus trap for suction9 (14.3)3(42.9)3 (75.0)3 (7.5) ## Acknowledgements Thanks to UNFPA for the financial support. In particular, we would like to register our appreciation to Dr Azzah Amin Said Nofly, Ms. Batula Abdi, and Ms Salma Yussuf, for their tireless efforts in ensuring this survey is a success. We also acknowledge Ministry of Health for its immense support and advice. We are also indebted to Mr. Ali Hassan from Zanzibar MoH for dayto-day field and administrative support during the whole period of the study. It would have been impossible to realize this work without the profound support from Dr Ali Omar Ali, the programme manager of the Integrated Reproductive and Child Health Programme, under the Ministry of Health, Zanzibar. Of equal importance, we would also like to thank the research assistants and participants of this study for their immense support. ## Ethics approval and consent to participate The research team worked with the Ministry of Health Zanzibar on necessary documents for ethical approval by Zanzibar Institute Review Board. All ethical guidelines were followed to ensure ethical conduct with participants. Authorities were contacted for their approval; the MoH issued an introductory letter from the ministry to each relevant authority. Participation into this study was voluntary, and researchers ensured confidentiality and privacy of participants. Participants signed an informed consent before interviews and were free to stop the interview at any time without repercussion. ## Consent for publication Study participants were informed on the dissemination of the finds without disclosing their personal identity and they agreed. ## Availability of data and materials The dataset analyzed during the current study are available from the corresponding author on reasonable request. ## Competing interest The authors declare that they have no competing interest. ## Funding This study was funded by United Nation Population Fund. ## Authors' contribution ABP, BS, SM and SL designed the study. SM, BS, SM and GS supervised data collection. CM and LBM analysed the data. ABP and SM drafted the first manuscript. All authors reviewed the subsequent drafts of the manuscript and approved the final version for submission. * Trends in maternal mortality UnicefWho UnfpaGroup WBNations U 1990 -2015. 2015 * The status of maternal and newborn health care services in Zanzibar BFakih AasNofly A OAli AMkopi AHassan A MAli BMC Pregnancy Childbirth 16 1 134 2016 * Determinants and causes of maternal mortality in Iran based on ICD-MM: a systematic review RZalvand MTajvar APourreza HAsheghi Reprod Health 16 1 16 2019 * Status of emergency obstetric care in six developing countries five years before the MDG targets for maternal and newborn health CAmeh SMsuya JHofman JRaven MMathai NVan Den Broek PLoS One 7 12 e49938 2012 * OCGS Office of Chief Government Statistician -OCGS/Zanzibar, ICF. Tanzania Demographic and Health Survey and Malaria Indicator Survey MohcdgecMinistry CDHealth Gender Children -Mohcdgec/TanzaniaElderly Mainland Moh Ministry /Health -Moh Zanzibar 2015 -2016. 2016 Dar es Salaam, Tanzania NBS National Bureau of Statistics -NBS/Tanzania * Population Distribution by Administrative Areas Nbs 2012. 2013 Population and Housing Census * P Background_information/2012_Census_General_ Report.pdf * Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group LAlkema DChou DHogan SZhang A BMoller AGemmill Lancet 387 2016. 10017 * Progress Made in Addressing Emergency Obstetric and Newborn Care Challenges in Zanzibar2019 A BPembe B FSunguya SLeshabari SMushi CMasaki KKiwango 19 * Needs Assessment of Emergency Obstetric and Newborn Care: Data Collection Modules Disability Aamda * Organization Wh Unfpa Unicef Disability. AMD. Monitoring emergency obstetric care 2009 * Everybody's business: strengthening health systems to improve health outcomes: WHO's framework for action Who 2007 * Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems LRoth DBempong J BBabigumira SBanoo ECooke DJeffreys Global Health 14 1 102 2018 * Perceived barriers to maternal and newborn health services delivery: a qualitative study of health workers and community members in low and middle-income settings JSumankuuro JCrockett SWang BMJ Open 8 11 e021223 2018 * Assessment of health facility capacity to provide newborn care in RWinter JYourkavitch WWang LMallick J Glob Health 7 2 20509 2017 * Quality medicines in maternal health: results of oxytocin, misoprostol, magnesium sulfate and calcium gluconate quality audits CAnyakora YOni UEzedinachi AAdekoya IAli CNwachukwu BMC Pregnancy Childbirth 18 1 44 2018 * Results-Based Financing in Mozambique's Central Medical Store: A Review After 1 Year CSpisak LMorgan REichler JRosen BSerumaga AWang Glob Health Sci Pract 4 1 2016 * Maternal mortality in Ifakara Health and Demographic Surveillance System: Spatial patterns, trends and risk factors A KManyeh RNathan GNelson PLoS One 13 10 e0205370 2006 -2010. 2018 * The evidence for emergency obstetric care APaxton DMaine LFreedman DFry SLobis Int J Gynaecol Obstet 88 2 2005 * Interagency list of medical devices for essential intervention for Reproductive, Maternal, Newborn and Child Health. Switzerland: World Health Organization 2015